Vor Bio to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Nov 7, 2025
BOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will participate in the following upcoming investor conferences:
Read more at globenewswire.com13.71
+1.3 (+10.48%)
Find more stocks in the Stock Screener
VOR Latest News and Analysis
